每年研究成果
每年研究成果
個人檔案
研究專長
藥事經濟學
藥物流行病學
健康經濟學
菸害防制
教育/學術資格
PhD, 醫療服務與政策, University of California, Berkeley
指紋
查看啟用 Yi-Wen Tsai 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Battle against time for innovative cancer treatment: an updated cost-effectiveness analysis of pemigatinib in intrahepatic cholangiocarcinoma
Wang, I. T., Chen, H. L., Huang, W. M., Chiang, N. J., Shen, L. J., Chueh, C. H. & Tsai, Y. W., 12月 2026, 於: Cost Effectiveness and Resource Allocation. 24, 1, 44.研究成果: Article › 同行評審
開啟存取 -
Correction: Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer (Scientific Reports, (2025), 15, 1, (39298), 10.1038/s41598-025-22966-4)
Chen, H. L., Chueh, C. H., Huang, W. M., Chan, S. H., Cheng, H. H., Chiang, S. C., Wu, C. E., Wen, Y. W. & Tsai, Y. W., 12月 2026, 於: Scientific reports. 16, 1, 18697.研究成果
開啟存取 -
Cost-effectiveness of lenvatinib plus pembrolizumab as the second-line treatment for advanced endometrial carcinoma
Chiang, S. T., Chueh, C. H., Wen, Y. W., Chiang, S. C., Li, W. H. & Tsai, Y. W., 12月 2026, 於: Cost Effectiveness and Resource Allocation. 24, 1, 42.研究成果: Article › 同行評審
開啟存取 -
Impact of artificial intelligence on cardiovascular workflow, engagement, and outcomes: a systematic review
Lin, Y. E., Yang, S. M., Huang, C. J., Tsai, Y. W., Cheng, H. M., Lee, W. C. & Wang, S. J., 12月 2026, 於: npj Digital Medicine. 9, 1, 536.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Association between prehospital medical service complexity and perceived task load of emergency calls among paramedics in Taiwan: a nationwide survey study
He, Y. W., Chueh, C. H., Yu, H. J., Huang, C. Y., Meng, Y. H., Lin, C. H., Tsai, Y. W., Kales, S. N. & Lan, F. Y., 12月 2025, 於: Scientific reports. 15, 1, 18201.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus）